psychiatric drugs trials

The Problem of Inflated Efficacy in Psychiatry Journals

Author: Editorial 25th October 2023 0 Comments

This article by Dr. Christopher Lane has been published in Psychology Today. It begins: “KEY POINTS New research finds widely prescribed drugs are much less effective than their published record suggests. One study saw financial conflicts of interest driving whether unfavorable…
Read more

a coherent system

Christopher Lane, efficacy, Journal of Clinical Epidemiology, Martin Plöderl, Michael Hengartner, pharmaceutical industry, psychiatric drugs trials, Psychology Today, Simone Amendola

Wishful thinking: antidepressant drugs in childhood depression

Author: Editorial 28th August 2023 0 Comments

This paper from Anne Tonkin and Jon Jureidini has been published in the British Journal of Psychiatry. It begins: “The use of selective serotonin reuptake inhibitors (SSRIs) in children under 18 years old increased ten-fold (from 0.5 to 4.6 per 1000)…
Read more

a coherent system

Anne Tonkin, antidepressants, British Journal of Psychiatry, children and adolescents, depression, Jon Jureidini, psychiatric drugs trials, psychiatry, SSRIs

Anatomy of an Industry: Commerce, Payments to Psychiatrists and Betrayal of the Public Good

Author: Editorial 15th April 2022 0 Comments

This article by Robert Whitaker has been written within an America context (but with wider applicability) and has been published by Mad in America. It begins: “The 2013 federal Open Payments legislation, which requires pharmaceutical companies to disclose their direct payments…
Read more

a coherent system

Mad in America, pharmaceutical industry, psychiatric drugs trials, psychiatry, Robert Whitaker, USA

The Visual Illusion of Efficacy in Psychiatric Drug Trials

Author: Editorial 11th November 2021 0 Comments

This article by Robert Whitaker has been published by Mad in America. It begins: “Published reports of clinical trials of psychiatric drugs typically include a graphic showing the efficacy of the study drug in reducing symptoms of the disorder compared with…
Read more

a coherent system

efficacy, Mad in America, Psychiatric Drugs, psychiatric drugs trials, Robert Whitaker

We Need a Thorough Investigation of the STAR*D Scandal

Author: admin 17th December 2018 0 Comments

This article by Robert Whitaker in the May 2011 edition of Psychology Today is well worth reading, despite it being published over seven years ago. Subtitled “Should reports from the NIMH’s STAR*D trial be retracted?”, it begins: “For some time now,…
Read more

collaborative practice

Ed Pigott, National Institute of Mental Health, psychiatric drugs trials, psychiatry, Psychology Today, Robert Whitaker, STAR*D Scandal

Looking for fresh articles?

The Problem of Inflated Efficacy in Psychiatry Journals

Wishful thinking: antidepressant drugs in childhood depression

Anatomy of an Industry: Commerce, Payments to Psychiatrists and Betrayal of the Public Good

The Visual Illusion of Efficacy in Psychiatric Drug Trials

We Need a Thorough Investigation of the STAR*D Scandal